Cargando…
Impact of controlling atrial fibrillation on outcomes relevant to the patient: focus on dronedarone
Atrial fibrillation (AF) is a substantial cause of mortality and morbidity in the Western world. It is a massive burden on health care systems, and its prevalence is expected to double over the next 20 years. Trials evaluating antiarrhythmic drugs or catheter ablation have focused on recurrence of a...
Autores principales: | Chahal, C Anwar A, Ali, Omer, Hunter, Ross J, Schilling, Richard J |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3557702/ https://www.ncbi.nlm.nih.gov/pubmed/23378791 http://dx.doi.org/10.2147/PROM.S16678 |
Ejemplares similares
-
Management of atrial fibrillation: focus on the role of dronedarone
por: Cheng, Judy WM
Publicado: (2011) -
Dronedarone in the management of atrial fibrillation
por: Saleem, TS Mohamed, et al.
Publicado: (2010) -
Cost considerations in the management of atrial fibrillation – impact of dronedarone
por: Khaykin, Yaariv, et al.
Publicado: (2012) -
Impact of dronedarone in atrial fibrillation and flutter on stroke reduction
por: Christiansen, Christine Benn, et al.
Publicado: (2010) -
Dronedarone for the treatment of atrial fibrillation and atrial flutter: approval and efficacy
por: Wolbrette, Deborah, et al.
Publicado: (2010)